Miran Kenk

941 total citations
37 papers, 701 citations indexed

About

Miran Kenk is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Miran Kenk has authored 37 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Miran Kenk's work include Prostate Cancer Treatment and Research (9 papers), Phosphodiesterase function and regulation (7 papers) and Receptor Mechanisms and Signaling (6 papers). Miran Kenk is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Phosphodiesterase function and regulation (7 papers) and Receptor Mechanisms and Signaling (6 papers). Miran Kenk collaborates with scholars based in Canada, United States and Georgia. Miran Kenk's co-authors include Romina Mizrahi, Pablo Rusjan, Sylvain Houle, Alan A. Wilson, Ivonne Suridjan, Gary Remington, Naren P. Rao, Jeffrey H. Meyer, Thiviya Selvanathan and Jean N. DaSilva and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Miran Kenk

34 papers receiving 694 citations

Peers

Miran Kenk
Lisa Wells United Kingdom
Cynthia Xu United States
Koichiro Fujimaki Japan
Maytal Shabat-Simon Israel
Avril Pereira Australia
I.S. Zimina Russia
Winston Corona United States
Martine Cleusix Switzerland
José Anton‐Rodriguez United Kingdom
Nicholas E. Clifton United Kingdom
Lisa Wells United Kingdom
Miran Kenk
Citations per year, relative to Miran Kenk Miran Kenk (= 1×) peers Lisa Wells

Countries citing papers authored by Miran Kenk

Since Specialization
Citations

This map shows the geographic impact of Miran Kenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miran Kenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miran Kenk more than expected).

Fields of papers citing papers by Miran Kenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miran Kenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miran Kenk. The network helps show where Miran Kenk may publish in the future.

Co-authorship network of co-authors of Miran Kenk

This figure shows the co-authorship network connecting the top 25 collaborators of Miran Kenk. A scholar is included among the top collaborators of Miran Kenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miran Kenk. Miran Kenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lajkosz, Katherine, et al.. (2023). Quantitative and qualitative impact of physician assistants in a Canadian urology setting. Canadian Urological Association Journal. 17(10). 337–340. 2 indexed citations
2.
Bellora, Camille, et al.. (2023). Biospecimen Qualification in a Clinical Biobank of Urological Diseases. Biopreservation and Biobanking. 22(3). 257–267.
3.
Herrera‐Cáceres, Jaime O., Tiange Li, Raj K. Tiwari, et al.. (2023). Age related differences in primary testicular lymphoma: A population based cohort study. Urologic Oncology Seminars and Original Investigations. 41(3). 151.e1–151.e10. 7 indexed citations
4.
Herrera‐Cáceres, Jaime O., et al.. (2022). Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers. Cancers. 14(4). 1004–1004. 8 indexed citations
5.
Herrera‐Cáceres, Jaime O., Miran Kenk, Katherine Lajkosz, et al.. (2022). Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes. Urologic Oncology Seminars and Original Investigations. 40(7). 343.e1–343.e6. 2 indexed citations
6.
Lajkosz, Katherine, Miran Kenk, Clive Woffendin, et al.. (2022). Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT). Urologic Oncology Seminars and Original Investigations. 40(5). 193.e15–193.e20. 4 indexed citations
7.
Wagner, Heidi, Miran Kenk, Michael Fraser, Alejandro Berlín, & Neil Fleshner. (2021). Biorepositories and Databanks for the Development of Novel Biomarkers for Genitourinary Cancer Prevention and Management. European Urology Focus. 7(3). 513–521. 2 indexed citations
8.
Kenk, Miran, et al.. (2020). Act Local, Think Global! The First ISBER-UHN Virtual Symposium. Biopreservation and Biobanking. 18(6). 592–593. 1 indexed citations
9.
Goldberg, Hanan, Refik Saskin, Girish S. Kulkarni, et al.. (2020). The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer. European Urology Focus. 7(3). 537–545. 15 indexed citations
10.
Hafizi, Sina, Huai‐Hsuan Tseng, Cory Gerritsen, et al.. (2018). Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum. Schizophrenia Research. 213. 80–86. 9 indexed citations
11.
Egerton, Alice, Oliver Howes, Sylvain Houle, et al.. (2016). Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis. Schizophrenia Bulletin. 43(2). sbw181–sbw181. 45 indexed citations
12.
Mizrahi, Romina, Miran Kenk, Ivonne Suridjan, et al.. (2013). Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use. Neuropsychopharmacology. 39(6). 1479–1489. 77 indexed citations
13.
Mizrahi, Romina, Ivonne Suridjan, Miran Kenk, et al.. (2012). Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO. Neuropsychopharmacology. 38(4). 673–682. 37 indexed citations
14.
Kenk, Miran, et al.. (2011). PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram. Current Radiopharmaceuticals. 4(1). 44–58. 10 indexed citations
15.
DaSilva, Jean N., Mireille Lortie, Jennifer M. Renaud, et al.. (2011). PET of (R)-11C-Rolipram Binding to Phosphodiesterase-4 Is Reproducible and Sensitive to Increased Norepinephrine in the Rat Heart. Journal of Nuclear Medicine. 52(2). 263–269. 11 indexed citations
16.
Thackeray, James T., et al.. (2011). Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats. Nuclear Medicine and Biology. 38(7). 1059–1066. 11 indexed citations
17.
Kenk, Miran, James T. Thackeray, Stephanie Thorn, et al.. (2010). Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity. Journal of Nuclear Cardiology. 17(2). 254–263. 28 indexed citations
18.
19.
Kenk, Miran, James T. Thackeray, Robert A. deKemp, et al.. (2006). In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues. Nuclear Medicine and Biology. 34(1). 71–77. 13 indexed citations
20.
Lourenço, Célia, Miran Kenk, Rob Beanlands, & Jean N. DaSilva. (2006). Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart. Life Sciences. 79(4). 356–364. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Wells Breakdown of academic impact, for papers by Cynthia Xu Breakdown of academic impact, for papers by Koichiro Fujimaki Breakdown of academic impact, for papers by Maytal Shabat-Simon Breakdown of academic impact, for papers by Avril Pereira Breakdown of academic impact, for papers by I.S. Zimina Breakdown of academic impact, for papers by Winston Corona Breakdown of academic impact, for papers by Martine Cleusix Breakdown of academic impact, for papers by José Anton‐Rodriguez Breakdown of academic impact, for papers by Nicholas E. Clifton
Rankless by CCL
2026